comparemela.com
Home
Live Updates
Mogrify and Astellas announce collaboration to conduct research on in vivo regenerative medicine approaches to address sensorineural hearing loss : comparemela.com
Mogrify and Astellas announce collaboration to conduct research on in vivo regenerative medicine approaches to address sensorineural hearing loss
/PRNewswire/ -- Mogrify Limited (CEO: Darrin M. Disley, Ph.D., "Mogrify®"), a biopharmaceutical company transforming the lives of patients through a novel...
Related Keywords
Bristol
,
City Of
,
United Kingdom
,
United States
,
Cambridge
,
Cambridgeshire
,
North Carolina
,
South San Francisco
,
California
,
San Francisco
,
Jonathan Milner
,
Mathew Pletcher
,
Linkedin Mogrify
,
Louise Modis
,
Darrinm Disley
,
J Public Health
,
Trend Investment Group
,
Astellas Pharma Inc
,
University Of Bristol Enterprise Fund
,
Zyme Communications
,
Astellas Center
,
Audentes Therapeutics Inc
,
Division Head
,
Gene Therapy Research
,
Technical Operations
,
Global Burden
,
Disease Study
,
Hearing Loss
,
Nature Genetics
,
Cell Systems
,
Ahren Innovation Capital
,
Bristol Enterprise Fund
,
Astellas Venture
,
Focus Area Approach
,
Audentes Therapeutics
,
comparemela.com © 2020. All Rights Reserved.